MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Prometheus IP

March 17, 2016by prometheusip0

MediciNova has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (Ibudilast) for the treatment of amyotrophic lateral sclerosis (ALS).[More]

prometheusip

Prometheus IP is a leading intellectual property service enterprise offering competent and economic Intellectual Property Rights (IPR) solutions which include Patents, Designs, Copyrights and Trademarks.

Our Wide Range of Services

Hyderabad
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social

Copyright Prometheus IP. All rights reserved.

Copyright Prometheus IP. All rights reserved.